Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
aMBMC in Heart Failure with LVAD
NCT03925324Phase 2Terminated
- Sponsor
- MedStar Health Research Institute
- Start
- May 2019
- Primary completion
- Aug 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic bone marrow-derived human mesenchymal stromal cells in heart failure (HF), sponsored by MedStar Health Research Institute. Started May 2019; status: terminated.
02
Drugs
allogeneic bone marrow-derived human mesenchymal stromal cells
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03925324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03925324.